Role of Ezetimibe in the Current Era in Treating Dyslipidemia in HIV-Infected Patients,Journal of the American College of Cardiology

当前位置： X-MOL 学术 › J. Am. Coll. Cardiol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Role of Ezetimibe in the Current Era in Treating Dyslipidemia in HIV-Infected Patients
Journal of the American College of Cardiology ( IF 24.0 ) Pub Date : 2020-09-01 , DOI: 10.1016/j.jacc.2020.06.084
Aniruddha Singh , Shilpi Mittal , Mohammed Kazimuddin

Boccara et al. ([1][1]) reported encouraging primary results of the randomized BEIJERINCK (EvolocumaB Effect on LDL-C Lowering in SubJEcts with Human Immunodeficiency VirRus and INcreased Cardiovascular RisK) study showing significant reductions in low-density lipoprotein cholesterol (LDL-C) using

中文翻译：

当代依折麦布在治疗 HIV 感染者血脂异常中的作用

博卡拉等人。([1][1]) 报告了随机 BEIJERINCK（EvolocumaB 对人类免疫缺陷病毒和心血管风险增加的受试者中 LDL-C 降低的影响）研究的令人鼓舞的初步结果，该研究显示低密度脂蛋白胆固醇 (LDL-C) 显着降低使用

更新日期：2020-09-01

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>